Pure Global

Early Detection of At-risk Septic Patients - Trial NCT06253325

Access comprehensive clinical trial information for NCT06253325 through Pure Global AI's free database. This phase not specified trial is sponsored by University Hospital Southampton NHS Foundation Trust and is currently Recruiting. The study focuses on Sepsis. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06253325
Recruiting
diagnostic test
Trial Details
ClinicalTrials.gov • NCT06253325
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Early Detection of At-risk Septic Patients
An Observational Pilot Study for the Multi-Modality Risk Prediction and Early Identification of Critically Ill Septic Patients in the Emergency Department

Study Focus

Sepsis

Measuring tissue oxygenation

Observational

diagnostic test

Sponsor & Location

University Hospital Southampton NHS Foundation Trust

Southampton, United Kingdom

Timeline & Enrollment

N/A

Jan 12, 2024

Aug 06, 2024

60 participants

Primary Outcome

Differences in tissue oxygenation

Summary

The purpose of this study is to determine whether additional investigations used in other
 parts of healthcare can be used in the Emergency Department to identify critically ill
 patients quicker than usual care.

ICD-10 Classifications

Other sepsis
Sepsis, unspecified
Other specified sepsis
Candidal sepsis
Puerperal sepsis

Data Source

ClinicalTrials.gov

NCT06253325

Non-Device Trial